Barton D J, Morasco B J, Flanegan J B
Department of Biochemistry, University of Florida College of Medicine, Gainesville, Florida 32610-0245, USA.
J Virol. 1999 Dec;73(12):10104-12. doi: 10.1128/JVI.73.12.10104-10112.1999.
Poliovirus has a single-stranded RNA genome of positive polarity that serves two essential functions at the start of the viral replication cycle in infected cells. First, it is translated to synthesize viral proteins and, second, it is copied by the viral polymerase to synthesize negative-strand RNA. We investigated these two reactions by using HeLa S10 in vitro translation-RNA replication reactions. Preinitiation RNA replication complexes were isolated from these reactions and then used to measure the sequential synthesis of negative- and positive-strand RNAs in the presence of different protein synthesis inhibitors. Puromycin was found to stimulate RNA replication overall. In contrast, RNA replication was inhibited by diphtheria toxin, cycloheximide, anisomycin, and ricin A chain. Dose-response experiments showed that precisely the same concentration of a specific drug was required to inhibit protein synthesis and to either stimulate or inhibit RNA replication. This suggested that the ability of these drugs to affect RNA replication was linked to their ability to alter the normal clearance of translating ribosomes from the input viral RNA. Consistent with this idea was the finding that the protein synthesis inhibitors had no measurable effect on positive-strand synthesis in normal RNA replication complexes. In marked contrast, negative-strand synthesis was stimulated by puromycin and was inhibited by cycloheximide. Puromycin causes polypeptide chain termination and induces the dissociation of polyribosomes from mRNA. Cycloheximide and other inhibitors of polypeptide chain elongation "freeze" ribosomes on mRNA and prevent the normal clearance of ribosomes from viral RNA templates. Therefore, it appears that the poliovirus polymerase was not able to dislodge translating ribosomes from viral RNA templates and mediate the switch from translation to negative-strand synthesis. Instead, the initiation of negative-strand synthesis appears to be coordinately regulated with the natural clearance of translating ribosomes to avoid the dilemma of ribosome-polymerase collisions.
脊髓灰质炎病毒具有正链单链RNA基因组,在受感染细胞的病毒复制周期开始时发挥两种基本功能。首先,它被翻译以合成病毒蛋白,其次,它被病毒聚合酶复制以合成负链RNA。我们通过使用HeLa S10体外翻译-RNA复制反应来研究这两个反应。从这些反应中分离出起始前RNA复制复合物,然后用于在存在不同蛋白质合成抑制剂的情况下测量负链和正链RNA的顺序合成。发现嘌呤霉素总体上刺激RNA复制。相反,白喉毒素、环己酰亚胺、茴香霉素和蓖麻毒素A链抑制RNA复制。剂量反应实验表明,抑制蛋白质合成以及刺激或抑制RNA复制需要精确相同浓度的特定药物。这表明这些药物影响RNA复制的能力与其改变输入病毒RNA上翻译核糖体正常清除的能力有关。与这一观点一致的是,蛋白质合成抑制剂对正常RNA复制复合物中的正链合成没有可测量的影响。与之形成鲜明对比的是,嘌呤霉素刺激负链合成,而环己酰亚胺抑制负链合成。嘌呤霉素导致多肽链终止并诱导多核糖体从mRNA上解离。环己酰亚胺和其他多肽链延伸抑制剂使核糖体“冻结”在mRNA上,并阻止核糖体从病毒RNA模板上正常清除。因此,似乎脊髓灰质炎病毒聚合酶无法将翻译核糖体从病毒RNA模板上移除并介导从翻译到负链合成的转换。相反,负链合成的起始似乎与翻译核糖体的自然清除协同调节,以避免核糖体-聚合酶碰撞的困境。